Demographics of the background population, persons with inflammatory bowel disease or rheumatic disease, all interferon gamma release assay tested persons, including persons diagnosed with tuberculosis and excluding persons diagnosed with tuberculosis, Denmark, 2010–2018. This evidence concerns the gene IFNG and inflammatory bowel disease.